Paper Suggests Making Drug Exclusivity Contingent On Reasonable Prices

The government should condition exclusivity on companies charging reasonable prices for drugs, according to health economist Len Nichols, who served as the senior health policy adviser to the Clinton White House. Nichols' proposal would control drug prices, lead to paying drug companies for performance and force drug makers to disclose their profit margins, research spending and marketing spending. A recent Kaiser Health tracking poll found that the public believes keeping drugs affordable for patients should be a priority for Congress,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.